SEC Form 4 · accession 0001225208-18-002197
Edwards Lifesciences Corp · EW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert W.A. Sellers
Officer — VP, Corporate Controller
Period of report
Feb 5, 2018
Accepted (ET)
Feb 6, 2018 · 9:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 5, 2018 | M | 8,120 | $44.615 | A | 25,113 | D | |
| Common StockF2 | Feb 5, 2018 | S | 1,400 | $130.9036 | D | 23,713 | D | |
| Common StockF3 | Feb 5, 2018 | S | 2,463 | $131.4663 | D | 21,250 | D | |
| Common StockF4 | Feb 5, 2018 | S | 2,500 | $131.6638 | D | 18,750 | D | |
| Common StockF5,F6 | Feb 5, 2018 | S | 5,657 | $130.5831 | D | 13,093 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Acquire) | $44.615 | Feb 5, 2018 | M | 8,120 | D | May 12, 2012 | May 11, 2018 | Common Stock | 8,120 | 0 | D |
Explanation of responses
- F1This amount includes quarterly acquisition of shares under the Edwards Lifesciences Corporation Employee Stock Purchase Plan as reflected on the most recent report of the plan administrator.
- F2This transaction was executed in multiple trades at prices ranging from $130.32 to $131.31. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- F3This transaction was executed in multiple trades at prices ranging from $131.14 to $131.8050. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- F4This transaction was executed in multiple trades at prices ranging from $131.34 to $132.05. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- F5This transaction was executed in multiple trades at prices ranging from $130.03 to $130.99. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- F6This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.
Remarks
sellerspoa.txt